含LcS发酵乳对抑郁合并便秘人群的影响

注册号:

Registration number:

ChiCTR1900025972 

最近更新日期:

Date of Last Refreshed on:

2019-09-16 13:51:24 

注册时间:

Date of Registration:

2019-09-16 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

含LcS发酵乳对抑郁合并便秘人群的影响

Public title:

Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota on Constipation of Depressed Patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

含LcS发酵乳对抑郁合并便秘人群的影响

Scientific title:

Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota on Constipation of Depressed Patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王然 

研究负责人:

任发政 

Applicant:

Wang Ran 

Study leader:

Ren Fazheng 

申请注册联系人电话:

Applicant telephone:

+86 13811855282

研究负责人电话:

Study leader's
telephone:

+86 010-62736344

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangran8609@126.com

研究负责人电子邮件:

Study leader's E-mail:

renfazheng@263.net

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区清华东路17号中国农业大学东校区食品学院

研究负责人通讯地址:

北京市海淀区清华东路17号中国农业大学东校区食品学院

Applicant address:

China Agricultural University East Campus, 17 Tsinghua Road East, Haidian District, Beijing, China

Study leader's address:

China Agricultural University East Campus, 17 Tsinghua Road East, Haidian District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国农业大学

Applicant's institution:

China Agricultural University

研究负责人所在单位:

中国农业大学

Affiliation of the Leader:

China Agricultural University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

CAUHR-2019014

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国农业大学人体研究伦理委员会

Name of the ethic committee:

Ethics Committee of China Agricultural University.

伦理委员会批准日期:

Date of approved by ethic committee:

2019-09-03 00:00:00

伦理委员会联系人:

车会莲

Contact Name of the ethic committee:

Che Huilian

伦理委员会联系地址:

北京市海淀区清华东路17号中国农业大学东校区

Contact Address of the ethic committee:

China Agricultural University East Campus, 17 Tsinghua Road East, Haidian District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国农业大学

Primary sponsor:

China Agricultural University.

研究实施负责(组长)单位地址:

北京市海淀区清华东路17号中国农业大学东校区食品学院

Primary sponsor's address:

China Agricultural University East Campus, 17 Tsinghua Road East, Haidian District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京市门头沟区医院

具体地址:

门头沟河滩桥东街10号

Institution
hospital:

Beijing Mentougou District Hospital

Address:

10 Hetanqiao Street East, Mentougou District

经费或物资来源:

养乐多(中国)投资有限公司

Source(s) of funding:

Yakult (China) Corporation

研究疾病:

抑郁合并便秘  

Target disease:

Constipation of Depressed Patients

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

研究副干酪乳杆菌LcS对抑郁人群的影响。  

Objectives of Study:

To investigate the effect of LcS on stool consistency of depressed patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 研究开始前30天内服用过抗生素或抗真菌类药物;
2. 研究开始前30天内服用过泻药;
3. 研究者不确定受试者是否能按照要求完成实验;
4. 牛奶过敏者、乳糖不耐、器质性或神经性便秘;
5. 妊娠期或哺乳期妇女;
6. 两周内开始服用抗抑郁药物;
7. 入组前两个月参与过其他研究。

Exclusion criteria:

1. Use of systemic antibiotics or antimycotics medication in the 30 days prior to the study.
2. Use of antidiarrheal or laxative medication in the 30 days prior to the study.
3. Investigator's uncertainty about the willingness or ability of subject to comply with the protocol requirements.
4. Persons with a milk protein allergy, lactose intolerance, or constipation of organic or neurological origin.
5. Pregnant or breastfeeding women.
6. Start using antidepressants within two weeks.
7. Participation in any other studies within two months prior to entry into the study.

研究实施时间:

Study execute time:

From 2019-09-04 00:00:00 To 2020-01-25 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-09-04 00:00:00 To 2019-10-20 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

25

Group:

experimental group

Sample size:

干预措施:

饮用养乐多产品

干预措施代码:

Intervention:

Yakult

Intervention code:

组别:

安慰剂组

样本量:

25

Group:

Placebo group

Sample size:

干预措施:

安慰剂

干预措施代码:

Intervention:

Placebo

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京市门头沟区医院 

单位级别:

二甲 

Institution
hospital:

Beijing Mentougou District Hospital

Level of the institution:

Secondary A

测量指标:

Outcomes:

指标中文名:

便秘严重程度

指标类型:

主要指标

Outcome:

severity of constipation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抑郁症状

指标类型:

次要指标

Outcome:

depressive symptoms

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肠道菌群

指标类型:

次要指标

Outcome:

intestinal microbiota

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清炎症因子(IL-6, IL-1β, TNF-α)

指标类型:

次要指标

Outcome:

mmune factors (IL-6, IL-1β, TNF-α)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清皮质醇

指标类型:

次要指标

Outcome:

serum cortisol

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清脑源性神经营养因子

指标类型:

次要指标

Outcome:

serum BDNF

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

Feces

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机化由冯博士团队完成。 随机化按是否服用抗抑郁药物分层。在每个阶层中,患者被随机分配到实验组和安慰剂组(1:1),每组25人。根据随机化代码预先包装产品。受试者、临床医生和分析人员对每个受试者的分组均不了解。

Randomization Procedure (please state who generates the random number sequence and by what method):

The randomization sequence was performed by Dr. Guoshuang Feng’s team . The codes were kept in sealed opaque envelopes allocated to patients according to strata. Each pack was assigned a number according to the randomization sequence.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

双盲

Blinding:

Double blind

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan, http://www.medresman.org

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan, http://www.medresman.org

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

ResMan

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2019-09-16 13:51:24